Simplex Trading’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.66M | Buy |
113,300
+88,100
| +350% | +$1.41M | ﹤0.01% | 2001 |
|
|
2025
Q4 | $194K | Sell |
25,200
-5,000
| -17% | -$39.4K | ﹤0.01% | 4265 |
|
|
2025
Q3 | $222K | Buy |
30,200
+18,200
| +152% | +$93.1K | ﹤0.01% | 4817 |
|
|
2025
Q2 | $48K | Sell |
12,000
-99,800
| -89% | -$363K | ﹤0.01% | 5957 |
|
|
2025
Q1 | $355K | Sell |
111,800
-351,700
| -76% | -$1.66M | ﹤0.01% | 3759 |
|
|
2024
Q4 | $2.48M | Buy |
463,500
+448,400
| +2,970% | +$3.35M | ﹤0.01% | 2009 |
|
|
2024
Q3 | $79K | Buy |
15,100
+11,000
| +268% | +$39.5K | ﹤0.01% | 5448 |
|
|
2024
Q2 | $7K | Sell |
4,100
-3,100
| -43% | -$5.78K | ﹤0.01% | 7652 |
|
|
2024
Q1 | $12K | Sell |
7,200
-600
| -8% | -$1.25K | ﹤0.01% | 7462 |
|
|
2023
Q4 | $13K | Buy |
7,800
+6,200
| +388% | +$9.06K | ﹤0.01% | 7234 |
|
|
2023
Q3 | $2K | Sell |
1,600
-3,300
| -67% | -$6.98K | ﹤0.01% | 8057 |
|
|
2023
Q2 | $11K | Buy |
4,900
+3,800
| +345% | +$7.89K | ﹤0.01% | 7300 |
|
|
2023
Q1 | $1K | Sell |
1,100
-34,300
| -97% | -$26.8K | ﹤0.01% | 8667 |
|
|
2022
Q4 | $30K | Sell |
35,400
-1,500
| -4% | -$1.33K | ﹤0.01% | 6456 |
|
|
2022
Q3 | $30K | Buy |
36,900
+24,100
| +188% | +$23K | ﹤0.01% | 7068 |
|
|
2022
Q2 | $12K | Sell |
12,800
-6,400
| -33% | -$7.85K | ﹤0.01% | 8113 |
|
|
2022
Q1 | $31K | Buy |
19,200
+12,500
| +187% | +$22.9K | ﹤0.01% | 7720 |
|
|
2021
Q4 | $16K | Buy |
6,700
+4,800
| +253% | +$18.6K | ﹤0.01% | 8603 |
|
|
2021
Q3 | $5K | Hold |
1,900
| – | – | ﹤0.01% | 9261 |
|
|
2021
Q2 | $5K | Buy |
1,900
+1,820
| +2,275% | +$5.01K | ﹤0.01% | 9444 |
|
|
2021
Q1 | $24K | Buy |
80
+65
| +433% | +$235 | ﹤0.01% | 7297 |
|
|
2020
Q4 | $5K | Buy |
+15
| New | +$60 | ﹤0.01% | 7702 |
|
Other funds holding CRVS
O
ASP
VCM
VC
DTC
